{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:52:58Z","timestamp":1753890778375,"version":"3.41.2"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R35NS111619"],"award-info":[{"award-number":["R35NS111619"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:italic>N<\/jats:italic>-Methyl-<jats:sc>D<\/jats:sc>-aspartate receptors (NMDARs) are highly expressed in brain and play important roles in neurodevelopment and various neuropathologic conditions. Here, we describe a new phenotype in an individual associated with a novel<jats:italic>de novo<\/jats:italic>deleterious variant in<jats:italic>GRIN1<\/jats:italic>(c.1595C&amp;gt;A, p.Pro532His). The clinical phenotype is characterized with developmental encephalopathy, striking stimulus-sensitive myoclonus, and frontal lobe and frontal white matter hypoplasia, with no apparent seizures detected. NMDARs that contained the P532H within the glycine-binding domain of GluN1 with either the GluN2A or GluN2B subunits were evaluated for changes in their pharmacological and biophysical properties, which surprisingly revealed only modest changes in glycine potency but a significant decrease in glutamate potency, an increase in sensitivity to endogenous zinc inhibition, a decrease in response to maximally effective concentrations of agonists, a shortened synaptic-like response time course, a decreased channel open probability, and a reduced receptor cell surface expression. Molecule dynamics simulations suggested that the variant can lead to additional interactions across the dimer interface in the agonist-binding domains, resulting in a more open GluN2 agonist-binding domain cleft, which was also confirmed by single-molecule fluorescence resonance energy transfer measurements. Based on the functional deficits identified, several positive modulators were evaluated to explore potential rescue pharmacology.<\/jats:p>","DOI":"10.3389\/fgene.2021.694312","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T08:19:59Z","timestamp":1627978799000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["A de novo GRIN1 Variant Associated With Myoclonus and Developmental Delay: From Molecular Mechanism to Rescue Pharmacology"],"prefix":"10.3389","volume":"12","author":[{"given":"Jin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiting","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi K.","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabina","family":"Paudyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenshu","family":"XiangWei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gil","family":"Shaulsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott J.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Dobyns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasanthi","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen F.","family":"Traynelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuhua","family":"Bozarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/cne.903470112","article-title":"Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats.","volume":"347","author":"Akazawa","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1113\/jphysiol.1990.sp018215","article-title":"A kinetic analysis of the modulation of N-methyl-D-aspartic acid receptors by glycine in mouse cultured hippocampal neurones.","volume":"428","author":"Benveniste","year":"1990","journal-title":"J. Physiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1021\/ct300400x","article-title":"Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone phi, psi and side-chain chi(1) and chi(2) dihedral angles.","volume":"8","author":"Best","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"B4","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/ejhg.2015.186","article-title":"Novel genetic causes for cerebral visual impairment.","volume":"24","author":"Bosch","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.coph.2014.11.008","article-title":"NMDA receptor subunit mutations in neurodevelopmental disorders.","volume":"20","author":"Burnashev","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejpn.2019.12.007","article-title":"GRIN2D\/GluN2D NMDA receptor: unique features and its contribution to pediatric developmental and epileptic encephalopathy.","volume":"24","author":"Camp","year":"2020","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/s0028-3908(00)00197-0","article-title":"Distinct effect of pregnenolone sulfate on NMDA receptor subtypes.","volume":"40","author":"Ceccon","year":"2001","journal-title":"Neuropharmacology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/jhg.2017.19","article-title":"GRIN1 mutation associated with intellectual disability alters NMDA receptor trafficking and function.","volume":"62","author":"Chen","year":"","journal-title":"J. Hum. Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1124\/mol.116.106781","article-title":"Functional evaluation of a de novo GRIN2A mutation identified in a patient with profound global developmental delay and refractory epilepsy.","volume":"91","author":"Chen","year":"","journal-title":"Mol. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bpj.2015.05.025","article-title":"Conformational transitions in the glycine-bound GluN1 NMDA receptor LBD via single-molecule FRET.","volume":"109","author":"Cooper","year":"2015","journal-title":"Biophys. J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/nchembio.2487","article-title":"The structure-energy landscape of NMDA receptor gating.","volume":"13","author":"Dolino","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1073\/pnas.1910950117","article-title":"Conformational spread and dynamics in allostery of NMDA receptors.","volume":"117","author":"Durham","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature12439","article-title":"De novo mutations in epileptic encephalopathies.","volume":"501","author":"Allen","year":"2013","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1523\/jneurosci.6041-10.2011","article-title":"Separation of domain contacts is required for heterotetrameric assembly of functional NMDA receptors.","volume":"31","author":"Farina","year":"2011","journal-title":"J. Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/gim.2014.154","article-title":"Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions.","volume":"17","author":"Farwell","year":"2015","journal-title":"Genet. Med."},{"key":"B16","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/brain\/awx358","article-title":"De novo mutations in GRIN1 cause extensive bilateral polymicrogyria.","volume":"141","author":"Fry","year":"2018","journal-title":"Brain"},{"key":"B17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature04089","article-title":"Subunit arrangement and function in NMDA receptors.","volume":"438","author":"Furukawa","year":"2005","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.str.2005.09.019","article-title":"Dynamic binding of PKA regulatory subunit RI alpha.","volume":"14","author":"Gullingsrud","year":"2006","journal-title":"Structure"},{"key":"B19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/jmedgenet-2016-103814","article-title":"Mutations in HECW2 are associated with intellectual disability and epilepsy.","volume":"53","author":"Halvardson","year":"2016","journal-title":"J. Med. Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ajhg.2011.02.001","article-title":"Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability.","volume":"88","author":"Hamdan","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pharmrev.120.000131","article-title":"Structure, function, and pharmacology of glutamate receptor ion channels.","volume":"73","author":"Hansen","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/gim.2015.186","article-title":"Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy.","volume":"18","author":"Helbig","year":"2016","journal-title":"Genet. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"10318","DOI":"10.1523\/jneurosci.2099-04.2004","article-title":"Molecular mechanism of pregnenolone sulfate action at NR1\/NR2B receptors.","volume":"24","author":"Horak","year":"2004","journal-title":"J. Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jphs.2016.10.002","article-title":"Human GRIN2B variants in neurodevelopmental disorders.","volume":"132","author":"Hu","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"B25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics.","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"B26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/mcse.2007.55","article-title":"Matplotlib: a 2D graphics environment.","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput. Sci. Eng."},{"key":"B27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature13908","article-title":"The contribution of de novo coding mutations to autism spectrum disorder.","volume":"515","author":"Iossifov","year":"2014","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1523\/jneurosci.22-06-02044.2002","article-title":"The NMDA receptor M3 segment is a conserved transduction element coupling ligand binding to channel opening.","volume":"22","author":"Jones","year":"2002","journal-title":"J. Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1126\/science.1251915","article-title":"Crystal structure of a heterotetrameric NMDA receptor ion channel.","volume":"344","author":"Karakas","year":"2014","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/tra.12073","article-title":"A novel assay for measurement of membrane-protein surface expression using a beta-lactamase.","volume":"14","author":"Lam","year":"2013","journal-title":"Traffic"},{"key":"B31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature13548","article-title":"NMDA receptor structures reveal subunit arrangement and pore architecture.","volume":"511","author":"Lee","year":"2014","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/nn.4352","article-title":"Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability.","volume":"19","author":"Lelieveld","year":"2016","journal-title":"Nat. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1212\/wnl.0000000000002740","article-title":"Delineating the GRIN1 phenotypic spectrum: a distinct genetic NMDA receptor encephalopathy.","volume":"86","author":"Lemke","year":"2016","journal-title":"Neurology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/346565a0","article-title":"Channel kinetics determine the time course of NMDA receptor-mediated synaptic currents.","volume":"346","author":"Lester","year":"1990","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.ajhg.2016.07.013","article-title":"GRIN2D recurrent de novo dominant mutation causes a severe epileptic encephalopathy treatable with NMDA receptor channel blockers.","volume":"99","author":"Li","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/humu.23895","article-title":"De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.","volume":"40","author":"Li","year":"2019","journal-title":"Hum. Mutat."},{"key":"B37","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neuropharm.2014.05.027","article-title":"Different oxysterols have opposing actions at N-methyl-D-aspartate receptors.","volume":"85","author":"Linsenbardt","year":"2014","journal-title":"Neuropharmacology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-9077-1_1","article-title":"Single-molecule FRET methods to study glutamate receptors.","volume":"1941","author":"Litwin","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/sj.bjp.0704543","article-title":"Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids.","volume":"135","author":"Malayev","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/338425a0","article-title":"Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine.","volume":"338","author":"Mayer","year":"1989","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.18949.1","article-title":"Distinct roles of GRIN2A and GRIN2B variants in neurological conditions.","volume":"8","author":"Myers","year":"2019","journal-title":"F1000Research"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006536","article-title":"Molecular mechanism of disease-associated mutations in the pre-M1 helix of NMDA receptors and potential rescue pharmacology.","volume":"13","author":"Ogden","year":"2017","journal-title":"PLoS Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/epi.12987","article-title":"GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders.","volume":"56","author":"Ohba","year":"2015","journal-title":"Epilepsia"},{"key":"B44","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"B45","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD.","volume":"26","author":"Phillips","year":"2005","journal-title":"J. Comput. Chem."},{"key":"B46","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/jmedgenet-2014-102554","article-title":"Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing.","volume":"51","author":"Redin","year":"2014","journal-title":"J. Med. Genet."},{"key":"B47","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/gim.2015.148","article-title":"Clinical application of whole-exome sequencing across clinical indications.","volume":"18","author":"Retterer","year":"2016","journal-title":"Genet. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/ejhg.2016.163","article-title":"Novel homozygous missense variant of GRIN1 in two sibs with intellectual disability and autistic features without epilepsy.","volume":"25","author":"Rossi","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.ajhg.2016.10.002","article-title":"Mechanistic insight into NMDA receptor dysregulation by rare variants in the GluN2A and GluN2B agonist binding domains.","volume":"99","author":"Swanger","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108247","article-title":"Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.","volume":"177","author":"Tang","year":"2020","journal-title":"Neuropharmacology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2011.52","article-title":"Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.","volume":"1","author":"Tarabeux","year":"2011","journal-title":"Transl. Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.1523\/jneurosci.18-16-06163.1998","article-title":"Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit.","volume":"18","author":"Traynelis","year":"1998","journal-title":"J. Neurosci."},{"key":"B53","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function.","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"B54","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/ana.24650","article-title":"Whole exome sequencing in patients with white matter abnormalities.","volume":"79","author":"Vanderver","year":"2016","journal-title":"Ann. Neurol."},{"key":"B55","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields.","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"8815","DOI":"10.1523\/jneurosci.0345-16.2016","article-title":"Chimeric glutamate receptor subunits reveal the transmembrane domain is sufficient for NMDA receptor pore properties but some positive allosteric modulators require additional domains.","volume":"36","author":"Wilding","year":"2016","journal-title":"J. Neurosci."},{"key":"B57","first-page":"333","article-title":"Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor.","volume":"40","author":"Wu","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cophys.2017.12.013","article-title":"De novo mutations and rare variants occurring in NMDA receptors.","volume":"2","author":"XiangWei","year":"2018","journal-title":"Curr. Opin. Physiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1093\/brain\/awz232","article-title":"Heterogeneous clinical and functional features of GRIN2D-related developmental and epileptic encephalopathy.","volume":"142","author":"XiangWei","year":"2019","journal-title":"Brain"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1021\/bi00057a007","article-title":"Molecular dynamics simulation of HIV-1 protease in a crystalline environment and in solution.","volume":"32","author":"York","year":"1993","journal-title":"Biochemistry"},{"key":"B61","doi-asserted-by":"publisher","first-page":"29708","DOI":"10.1074\/jbc.m414215200","article-title":"Conserved structural and functional control of N-methyl-D-aspartate receptor gating by transmembrane domain M3.","volume":"280","author":"Yuan","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B62","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1124\/mol.115.097998","article-title":"Ionotropic GABA and glutamate receptor mutations and human neurologic diseases.","volume":"88","author":"Yuan","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ejmg.2017.04.001","article-title":"De novo GRIN1 mutations: an emerging cause of severe early infantile encephalopathy.","volume":"60","author":"Zehavi","year":"2017","journal-title":"Eur. J. Med. Genet."},{"key":"B64","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/gim.2014.191","article-title":"Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios.","volume":"17","author":"Zhu","year":"2015","journal-title":"Genet. Med."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.694312\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T20:49:27Z","timestamp":1699303767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.694312\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":64,"alternative-id":["10.3389\/fgene.2021.694312"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2021.694312","relation":{},"ISSN":["1664-8021"],"issn-type":[{"type":"electronic","value":"1664-8021"}],"subject":[],"published":{"date-parts":[[2021,8,3]]},"article-number":"694312"}}